Pharmacovigilance: methods, recent developments and future perspectives L. HärmarkA. C. van Grootheest Review Article 04 June 2008 Pages: 743 - 752
Clinical pharmacology and pharmacogenetics of thiopurines Srikumar SahasranamanDanny HowardSandip Roy Review Article 28 May 2008 Pages: 753 - 767
Medication errors made by health care professionals. Analysis of the Finnish Poison Information Centre data between 2000 and 2007 Tapio KuitunenPia KuismaKalle Hoppu Clinical Trial 30 May 2008 Pages: 769 - 774
CYP3A induction and inhibition by different antiretroviral regimens reflected by changes in plasma 4β-hydroxycholesterol levels F. JosephsonL. BertilssonU. Diczfalusy Pharmacodynamics 06 May 2008 Pages: 775 - 781
The importance of sample size, log-mean ratios, and intrasubject variability in the acceptance criteria of 108 bioequivalence studies E. RamirezP. GuerraJ. Frias Pharmacokinetics and Disposition 21 May 2008 Pages: 783 - 793
Pharmacokinetic–pharmacodynamic modeling of the influence of chronic phenytoin therapy on the rocuronium bromide response in patients undergoing brain surgery Juan Fernández-CandilPedro L. GambúsNeus Fábregas Pharmacokinetics and Disposition 03 June 2008 Pages: 795 - 806
Prediction of cyclosporine A blood levels: an application of the adaptive-network-based fuzzy inference system (ANFIS) in assisting drug therapy Sezer GörenAdem KarahocaM. Zafer Gören Pharmacokinetics and Disposition 06 May 2008 Pages: 807 - 814
Cholesterol in women at high cardiovascular risk is less successfully treated than in corresponding men Anita MehnerUlf LindbladKristina Bengtsson Boström Pharmacoepidemiology and Prescription 04 April 2008 Pages: 815 - 820
Outpatient antibiotic use and assessment of antibiotic guidelines in Chinese children’s hospitals Wenshuang ZhangXuzhuang ShenYonghong Yang Pharmacoepidemiology and Prescription 06 May 2008 Pages: 821 - 828
Was the thrombotic risk of rofecoxib predictible from the French Pharmacovigilance Database before 30 September 2004? A. SommetS. GrolleauFrench Network of Regional Pharmacovigilance Centres Pharmacoepidemiology and Prescription 29 May 2008 Pages: 829 - 834